Christopher B. Granger

Research interests

Publications

• Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation

  New England Journal of Medicine · 2019 · 10.1056/nejmoa1901183

• Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1817083

• Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1813959

• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32261-x

• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

  Journal of the American College of Cardiology · 2018 · https://doi.org/10.1016/j.jacc.2017.10.054

• Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1609581

• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

  Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.03.513

• Relationship Between Infarct Size and Outcomes Following Primary PCI

  Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.01.069

• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischem

  Circulation · 2016 · 10.1161/cir.0000000000000404

• Fundamentals of Clinical Trials

  Journal · 2015 · 10.1007/978-3-319-18539-2

• Embolic strokes of undetermined source: the case for a new clinical construct

  The Lancet Neurology · 2014 · 10.1016/s1474-4422(13)70310-7

• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

  New England Journal of Medicine · 2013 · 10.1056/nejmoa1300615

• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

  Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2012.11.018

• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

  Circulation · 2012 · 10.1161/cir.0b013e3182742c84

• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

  Circulation · 2012 · 10.1161/cir.0b013e3182742cf6

• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

  Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2012.11.019

• Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure

  Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.02.067

• A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction

  Science · 2007 · 10.1126/science.1142842

• Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

  BMJ · 2006 · 10.1136/bmj.38985.646481.55

• Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

  Circulation · 2006 · 10.1161/circulationaha.105.580506

• Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

  Circulation · 2005 · 10.1161/circulationaha.105.561423

• Predictors of mortality and morbidity in patients with chronic heart failure

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi555

• A Validated Prediction Model for All Forms of Acute Coronary Syndrome

  JAMA · 2004 · 10.1001/jama.291.22.2727

• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14284-5

• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

  The Lancet · 2003 · 10.1016/s0140-6736(03)14282-1

• Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events

  Archives of Internal Medicine · 2003 · 10.1001/archinte.163.19.2345

• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14283-3

• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14285-7

• Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

  CHEST Journal · 2001 · 10.1378/chest.119.1_suppl.64s

• Heparin and Low-Molecular-Weight Heparin

  CHEST Journal · 1998 · 10.1378/chest.114.5_supplement.489s

• Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

  New England Journal of Medicine · 1996 · 10.1056/nejm199610313351801

Current projects

No projects listed.